Compare DXYZ & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXYZ | FULC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.6M | 468.1M |
| IPO Year | 2024 | 2019 |
| Metric | DXYZ | FULC |
|---|---|---|
| Price | $31.51 | $11.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $16.38 |
| AVG Volume (30 Days) | N/A | ★ 2.6M |
| Earning Date | N/A | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2752.05 |
| 52 Week Low | N/A | $2.32 |
| 52 Week High | N/A | $15.74 |
| Indicator | DXYZ | FULC |
|---|---|---|
| Relative Strength Index (RSI) | 58.37 | 53.04 |
| Support Level | $29.11 | $11.98 |
| Resistance Level | $33.62 | $12.90 |
| Average True Range (ATR) | 3.26 | 1.17 |
| MACD | 0.17 | -0.08 |
| Stochastic Oscillator | 41.23 | 45.50 |
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.